Monoclonal Gammopathy of Undetermined Significance
"Monoclonal Gammopathy of Undetermined Significance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia.
MeSH Number(s)
C15.378.147.542.640
C20.683.460.640
C20.683.780.640
Concept/Terms
Monoclonal Gammopathy of Undetermined Significance- Monoclonal Gammopathy of Undetermined Significance
- Monoclonal Gammapathies, Benign
- Benign Monoclonal Gammapathies
- Benign Monoclonal Gammapathy
- Gammapathies, Benign Monoclonal
- Gammapathy, Benign Monoclonal
- Monoclonal Gammapathy, Benign
- Monoclonal Gammopathies, Benign
- Benign Monoclonal Gammopathies
- Benign Monoclonal Gammopathy
- Gammopathies, Benign Monoclonal
- Gammopathy, Benign Monoclonal
- Monoclonal Gammopathy, Benign
- Monoclonal Gammapathy of Undetermined Significance
Below are MeSH descriptors whose meaning is more general than "Monoclonal Gammopathy of Undetermined Significance".
Below are MeSH descriptors whose meaning is more specific than "Monoclonal Gammopathy of Undetermined Significance".
This graph shows the total number of publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in Harvard Catalyst Profiles by year, and whether "Monoclonal Gammopathy of Undetermined Significance" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 3 | 5 |
| 2015 | 4 | 3 | 7 |
| 2016 | 5 | 1 | 6 |
| 2017 | 2 | 2 | 4 |
| 2018 | 6 | 1 | 7 |
| 2019 | 6 | 1 | 7 |
| 2020 | 3 | 0 | 3 |
| 2021 | 2 | 1 | 3 |
| 2022 | 9 | 0 | 9 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Monoclonal Gammopathy of Undetermined Significance" by people in Profiles.
-
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study. Lancet Haematol. 2023 Mar; 10(3):e203-e212.
-
The promise and harms of screening for plasma cell dyscrasias. Br J Haematol. 2023 03; 200(6):704-707.
-
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2192-2198.
-
Identifying monoclonal gammopathy of undetermined significance from electronic health records. Cancer Rep (Hoboken). 2023 03; 6(3):e1755.
-
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy. Blood Cancer J. 2022 11 24; 12(11):160.
-
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance. Blood. 2022 11 03; 140(18):1997-2000.
-
The evolution of immune dysfunction in multiple myeloma. Eur J Haematol. 2022 Nov; 109(5):415-424.
-
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia. Acta Haematol. 2022; 145(6):619-626.
-
Prevalence of monoclonal gammopathy of undetermined significance in US black women. Am J Hematol. 2022 09; 97(9):E341-E343.
-
When a Monoclonal Gammopathy Is Not Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-10.